Reading Time: 6 minutesMND EnCouRage UK is our annual event which aims to celebrate and support the work of researchers who are just beginning their careers in MND,
Tag: clinical trials

Reading Time: 7 minutesThere is an urgent need for more effective treatments for MND. Researchers are focused on identifying more potential treatments for the disease and these are

Reading Time: 6 minutesThe results of the MIROCALS clinical trial into the effects of low dose interleukin-2 (IL-2) on people with MND have now been published in The

Reading Time: 6 minutesNew and effective treatments for MND are urgently needed and many scientists around the world are working towards this goal. Throughout 2024, we saw many

UK clinical trial updates to look out for in 2025
Reading Time: 6 minutesNew and effective treatments for MND are urgently needed and many scientists around the world are working towards this. Throughout 2024, we saw many new

Finding treatments and improving care in MND
Reading Time: 7 minutesIt’s that time of year again when we’re counting down to the annual International Symposium on ALS/MND! This year marks the 35th Symposium, the largest scientific

Reading Time: 10 minutesFor the purposes of this blog, ALS should be taken to mean ALS/MND. In September 2020 we published a blog article discussing Dr Rick Bedlack’s

Reading Time: 5 minutes"New drug reduces risk of death by 50%"
You may have seen this type of headline in news articles reporting on the outcome of clinical trials. Reading this headline can lead people to believe a potential drug is highly beneficial and has a real impact. However, it is important to delve a little deeper into the meaning of ‘risk of death’, the raw data behind it, and how it should be considered alongside other outcome measures of a trial to fully determine how effective a drug might be.